Filter
686
Text search:
lung
cancer
Featured
Recommendations
84
New Publications
144
Language
Document type
No document type
336
Studies & Reports
131
Guidelines
107
Manuals
42
Strategic & Response Plan
25
Fact sheets
21
Training Material
11
Situation Updates
4
Brochures
3
Infographics
2
Online Courses
2
App
1
Resource Platforms
1
Countries / Regions
India
57
Global
50
Western and Central Europe
29
Kenya
28
South Africa
23
Ethiopia
16
Philippines
13
Latin America and the Carribbean
10
Eastern Europe
10
Uganda
9
Tanzania
9
Indonesia
9
South–East Asia Region
9
Eastern Europe and Central Asia
9
Africa
9
Nigeria
8
Rwanda
8
Zambia
7
Bangladesh
7
Malawi
7
Nepal
6
Namibia
6
Myanmar / Burma
6
Ghana
5
Germany
5
Lesotho
5
Russia
5
USA
4
Ukraine
4
Botswana
4
Asia
4
Mozambique
3
Brazil
3
Sierra Leone
2
Liberia
2
Senegal
2
Zimbabwe
2
Iraq
2
Syria
2
Cambodia
2
China
2
Colombia
2
Mexico
2
East and Southern Africa
2
Middle East and North Africa
2
Paraguay
2
Tajikistan
2
Moldova
2
Guinea
1
Burkina Faso
1
Congo, Democratic Republic of
1
Haiti
1
Pakistan
1
Sudan
1
Argentina
1
Peru
1
Eswatini/ Swaziland
1
Switzerland
1
Yemen
1
Western Pacific Region
1
Other region
1
Venezuela
1
Georgia
1
Vietnam
1
North America
1
Azerbaijan
1
Authors & Publishers
Publication Years
Category
Countries
263
Public Health
79
Clinical Guidelines
67
Women & Child Health
22
Key Resources
11
Capacity Building
9
Pharmacy & Technologies
6
Toolboxes
COVID-19
76
TB
67
NCDs
66
Planetary Health
53
Mental Health
44
HIV
24
Global Health Education
17
Caregiver
16
Pharmacy
15
Refugee
13
Specific Hazards
12
AMR
8
NTDs
5
Polio
4
Conflict
4
Social Ethics
4
Rapid Response
3
Disability
2
Ebola
2
Natural Hazards
2
Health Financing Toolbox
2
Cholera
1
Examination of the business behavior of Boehringer Ingelheim, Bayer and Baxter in India
(Health Systems in Transition, Vol. 4, No. 3, 2014)
Alcohol, medication, tobacco, illegal drugs, addictive behaviour
Second, revised edition with new layout
Juni 2014
This document sets out the preparedness and response plan of the Nigerian Primary Health Care System for COVID-19 Acute Respiratory Disease. It outlines the planning scenarios, key areas of work and priority activities required for the Primary Health Care Sector to quickly scale up its core capacity
...
The WHO COVID-19 Clinical management: living guidance contains the Organization’s most up-to-date recommendations for the clinical management of people with COVID-19. Providing guidance that is comprehensive and holistic for the optimal care of COVID-19 patients throughout their entire illness is
...
Infection prevention and control in the context of coronavirus disease (COVID-19): A living guideline
recommended
This second edition of the Infection prevention and control in the context of coronavirus disease (COVID-19): A living guideline provides the most up to date technical guidance on mask use in community settings in the context of COVID-19.
In this edition, new information includes updated mask re
...
In 2015, 26% of the deaths of 5.9 million children who died before reaching their fifth birthday could have been prevented
through addressing environmental risks – a shocking missed opportunity. The prenatal and early childhood period represents
a window of particular vulnerability, where enviro
...
As of 12 December 2022, over 645 million people worldwide have been diagnosed with COVID-19, with over 6.6 million deaths (4).
The Omicron variant, which emerged in late November 2021, and its subvariants, are now the dominant circulating viruses, contributing to the ongoing surge in several countr
...
The WHO continuously reviews available data on SARS-CoV-2 variants of concern. For this version, the global epidemiological
situation of the COVID-19 pandemic as of 21 January 2022 – at a time when the Omicron VOC had been identified in 171
countries across all six WHO Regions and was rapidly re
...
The WHO COVID-19 Clinical management: living guidance contains the most up-to-date recommendations for the clinical management of people with COVID-19. Providing guidance that is comprehensive and holistic for the optimal care of COVID-19 patients throughout their entire illness is important.
Health Systems in Transition. Vol. 5 No.3 2015
A new frontier for integrated care.
Until now, most efforts to promote integrated care have focused on bridging the gaps between health and social care or between primary and secondary care. But the NHS five year forward view has highlighted a third dimension – bringing together physical and ment
...
UNAIDS 2016, Reference
HIV care and support taking into account the 2016 WHO consolidated guidelines
The Global Strategy for Tuberculosis Research and Innovation will support the efforts of governments and other stakeholders to accelerate TB research and innovation, and improve equitable access to the benefits of research.
Availabl in Arabic, Chinese, English, French, Spanish and Russian
Interim Guidance October 2022. This addendum addresses some of the methodological aspects of VE evaluations that have been learned during the past year, as well as those that have become relevant in the current epidemiological setting of the COVID-19 pandemic. For some of the COVID-19 vaccine method
...
The Faster We Go, the Health We'll Be.
The report outlines five climate solutions that research shows will deliver immediate, often localized, health and equity benefits. Our focus is on the solutions that proactively advance both health and health equity, recognizing that some of us face greater h
...
